India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise
BUZZ-India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise ** Shares of India's Dr Lal PathLabs DLPA.NS rise 6.2% to 1868 rupees, their highest level since January 2022
** Indian diagnostics firm reported 28.8% y/y increase in Q1 profit; rev from ops up 19% y/y
** Analysts at Citi ("buy") raise TP to 2160 rupees from 1950 rupees; say management's mid-teens rev growth guidance for FY27 is "conservative" considering DLPA's network expansion and deepening market penetration
** Analysts at UBS ("buy") raise TP to 2100 rupees from 1850 rupees, citing strongest patient volume growth in recent quarters
** More than 980,000 shares traded by 10:13 AM, 1.6x the 30-day avg
** DLPA on avg rated "buy" by 21 analysts; median PT is 1950 rupees - LSEG-compiled data
** Stock up 26% YTD
(Reporting by Abhirami G in Bengaluru)
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise